Chapter 1 INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2 EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter 3 MARKET OVERVIEW

3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top Player Positioning/Market Share Analysis, 2017
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Porters Five Forces Analysis

Chapter 4 MEXICAN INTRAOCULAR LENS MARKET, BY TYPE

4.1. Overview
4.1.1. Market size and forecast
4.2. Monofocal Intraocular Lens
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast (Value and Volume)
4.3. Premium Intraocular Lens
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast (Value and Volume)
4.3.3. Market size and forecast, by type
4.3.3.1. Toric intraocular lens
4.3.3.1.1. Market size and forecast
4.3.3.2. Multifocal intraocular lens
4.3.3.2.1. Market size and forecast
4.3.3.3. Accommodating intraocular lens
4.3.3.3.1. Market size and forecast
4.3.3.4. Other intraocular lenses
4.3.3.4.1. Market size and forecast

Chapter 5 MEXICAN INTRAOCULAR LENS MARKET, BY END USER

5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Market size and forecast (Value and Volume)
5.3. Ambulatory Surgical Centers (ASCS)
5.3.1. Market size and forecast (Value and Volume)
5.4. Ophthalmology Clinics
5.4.1. Market size and forecast (Value and Volume)
5.5. Eye Research Institutes
5.5.1. Market size and forecast (Value and Volume)

Chapter 6 MEXICAN INTRAOCULAR LENS MARKET, BY MATERIAL

6.1. Overview
6.1.1. Market size and forecast
6.2. Polymethyl Methacrylate (PMMA)
6.2.1. Market size and forecast
6.3. Silicone
6.3.1. Market size and forecast
6.4. Hydrophobic Acrylic
6.4.1. Market size and forecast

Chapter 7 COMPANY PROFILES

7.1. Novartis AG (Alcon México)
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. Carl Zeiss Meditec AG
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. Johnson & Johnson
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. Rayner Intraocular Lens, Ltd.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. Valeant Pharmaceuticals International, Inc.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. Bausch & Lomb Incorporated
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. CIMA Technology, Inc.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. Abbott Laboratories
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. Ophtec BV
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. PhysIOL
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments